Eisler Capital (Us) LLC Amicus Therapeutics, Inc. Transaction History
Eisler Capital (Us) LLC
- $5.6 Trillion
- Q2 2024
A detailed history of Eisler Capital (Us) LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Eisler Capital (Us) LLC holds 83,110 shares of FOLD stock, worth $930,831. This represents 0.01% of its overall portfolio holdings.
Number of Shares
83,110
Previous 60,383
37.64%
Holding current value
$930,831
Previous $711 Million
15.91%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding FOLD
# of Institutions
278Shares Held
324MCall Options Held
260KPut Options Held
261K-
Vanguard Group Inc Valley Forge, PA28.6MShares$320 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$314 Million8.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY27.4MShares$307 Million3.71% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$273 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA21.1MShares$236 Million0.04% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $3.14B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...